CS248731B2 - Production method of the phenyl dihydropyridazinon derivatives - Google Patents

Production method of the phenyl dihydropyridazinon derivatives Download PDF

Info

Publication number
CS248731B2
CS248731B2 CS85202A CS20285A CS248731B2 CS 248731 B2 CS248731 B2 CS 248731B2 CS 85202 A CS85202 A CS 85202A CS 20285 A CS20285 A CS 20285A CS 248731 B2 CS248731 B2 CS 248731B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
compounds
formula
phenyl
dihydro
Prior art date
Application number
CS85202A
Other languages
Czech (cs)
English (en)
Inventor
Robert A Slater
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of CS248731B2 publication Critical patent/CS248731B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Hydrogenated Pyridines (AREA)
CS85202A 1984-01-13 1985-01-10 Production method of the phenyl dihydropyridazinon derivatives CS248731B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400863A GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds

Publications (1)

Publication Number Publication Date
CS248731B2 true CS248731B2 (en) 1987-02-12

Family

ID=10554924

Family Applications (1)

Application Number Title Priority Date Filing Date
CS85202A CS248731B2 (en) 1984-01-13 1985-01-10 Production method of the phenyl dihydropyridazinon derivatives

Country Status (31)

Country Link
US (1) US4654342A (fr)
EP (1) EP0150937B1 (fr)
JP (3) JPS60158181A (fr)
KR (1) KR920006781B1 (fr)
CN (1) CN85101722A (fr)
AT (1) ATE37179T1 (fr)
AU (1) AU572252B2 (fr)
CA (2) CA1251209A (fr)
CS (1) CS248731B2 (fr)
DD (1) DD231350A5 (fr)
DE (1) DE3564941D1 (fr)
DK (1) DK162519C (fr)
ES (3) ES8607949A1 (fr)
FI (1) FI850140L (fr)
GB (1) GB8400863D0 (fr)
GR (1) GR850068B (fr)
HU (1) HU193591B (fr)
IE (1) IE57969B1 (fr)
IL (1) IL74031A (fr)
JO (1) JO1351B1 (fr)
MY (1) MY100124A (fr)
NO (1) NO850129L (fr)
NZ (1) NZ210816A (fr)
PH (1) PH22136A (fr)
PL (1) PL147123B1 (fr)
PT (1) PT79819B (fr)
RO (1) RO92607A (fr)
SU (1) SU1396963A3 (fr)
WO (1) WO1985003076A1 (fr)
ZA (1) ZA85251B (fr)
ZW (1) ZW385A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251448A (fr) * 1985-03-27 1989-03-21 William J. Coates Derives de pyridazinone
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
AU2002254124A1 (en) 2001-02-27 2002-09-12 Mitokor Aryl-n-cyanoguanidines and methods related thereto
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (fr) * 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions
ES2631879T3 (es) * 2005-11-14 2017-09-05 Boehringer Ingelheim Vetmedica Gmbh Uso de pimobendano para el tratamiento de la insuficiencia cardíaca asintomática (oculta)
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (fr) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
MX2011005444A (es) 2008-11-25 2011-06-09 Boehringer Ingelheim Vetmed Inhibidores de la fosfodiesterasa tipo iii (pde iii) o agentes sensibilizantes a iones de ca(2+) para el tratamiento de la cardiomiopatia hipertrofica.
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828346C (fr) 2011-03-01 2021-01-26 Synergy Pharmaceuticals Inc. Procede de preparation d'agonistes du guanylate cyclase c
WO2013106547A1 (fr) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EP3718557A3 (fr) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Agoniste du récepteur de la guanylate cyclase sp-333 à utiliser lors du nettoyage du côlon
EP2970384A1 (fr) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
CA2920856A1 (fr) 2013-08-09 2015-02-12 Ardelyx, Inc. Composes modulant le ph pour diminuer l'absorption gastro-intestinale dephosphate
CA3176466A1 (fr) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Compositions pharmaceutiques ameliorees de pimobendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822260A (en) * 1970-10-09 1974-07-02 American Cyanamid Co 6-(cyanophenyl)-4,5-dihydro-3(2h)-pyridazinones
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
EP0030835B1 (fr) * 1979-12-05 1983-05-11 Morishita Pharmaceutical Co. Ltd. Dérivés de 6-phényl-3(2H)-pyridazinones substituées en position 2, leur production et compositions pharmaceutiques les contenant
FI72718C (fi) * 1981-03-04 1987-07-10 Ciba Geigy Ag Foerfarande foer framstaellning av terapeutiskt verkande, substituerade 6-(4-morfolino-fenyl)-4,5-dihydro- 3(2h)-pyridazinoner och deras syraadditionssalter.
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
JPS58140076A (ja) * 1982-02-09 1983-08-19 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
DE3204375C2 (de) * 1982-02-09 1983-12-01 J. Rettenmaier & Söhne GmbH + Co, 7091 Holzmühle Verfahren zur Herabsetzung der Saugfähigkeit von Holz
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
US4946842A (en) * 1985-07-05 1990-08-07 Smith Kline & French Laboratories Limited Novel guanidino pyridazinones as cardiac stimulants

Also Published As

Publication number Publication date
DK162519B (da) 1991-11-11
HUT37128A (en) 1985-11-28
DK9185D0 (da) 1985-01-08
ES554965A0 (es) 1987-07-01
NO850129L (no) 1985-07-15
IL74031A (en) 1988-07-31
JPS60158181A (ja) 1985-08-19
ES8607949A1 (es) 1986-06-01
JPS63313776A (ja) 1988-12-21
ATE37179T1 (de) 1988-09-15
GR850068B (fr) 1985-05-03
PH22136A (en) 1988-06-01
HU193591B (en) 1987-11-30
AU3761185A (en) 1985-07-18
ES8703846A1 (es) 1987-03-01
CA1251209A (fr) 1989-03-14
EP0150937B1 (fr) 1988-09-14
JPS63313775A (ja) 1988-12-21
ES8706645A1 (es) 1987-07-01
NZ210816A (en) 1987-06-30
PT79819B (en) 1987-01-07
IE850069L (en) 1985-07-13
IE57969B1 (en) 1993-06-02
ZW385A1 (en) 1985-08-07
DK9185A (da) 1985-07-14
ZA85251B (en) 1986-08-27
CA1260471C (fr) 1989-09-26
DE3564941D1 (en) 1988-10-20
MY100124A (en) 1989-12-18
FI850140L (fi) 1985-07-14
DK162519C (da) 1992-03-30
KR920006781B1 (ko) 1992-08-17
GB8400863D0 (en) 1984-02-15
EP0150937A3 (en) 1985-08-21
AU572252B2 (en) 1988-05-05
FI850140A0 (fi) 1985-01-11
PL147123B1 (en) 1989-04-29
WO1985003076A1 (fr) 1985-07-18
US4654342A (en) 1987-03-31
EP0150937A2 (fr) 1985-08-07
RO92607A (fr) 1987-11-30
ES549629A0 (es) 1987-03-01
PT79819A (en) 1985-02-01
JO1351B1 (en) 1986-11-30
PL251516A1 (en) 1985-12-17
CN85101722A (zh) 1987-01-31
KR850005417A (ko) 1985-08-26
DD231350A5 (de) 1985-12-24
IL74031A0 (en) 1985-04-30
CA1260471A (fr) 1989-09-26
ES539446A0 (es) 1986-06-01
SU1396963A3 (ru) 1988-05-15

Similar Documents

Publication Publication Date Title
CS248731B2 (en) Production method of the phenyl dihydropyridazinon derivatives
RU2068844C1 (ru) Производные азотсодержащих гетероциклических соединений или их фармацевтически приемлемые соли с щелочными или щелочно-земельными металлами
DE69030206T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
CZ277698B6 (en) Racemic or optically active bis-aza-bicyclic compounds, process for preparing thereof, intermediates and use thereof
EP0208518B1 (fr) Composés 6-phényl-pyridazinyliques
FR2479225A1 (fr) Imidazopyridines, leur preparation et leur utilisation comme agents cardiotoniques
EP0201988B1 (fr) Dérivés de dihydropyridazinone
LU82728A1 (fr) 6-(pyridinyl)-3(2h)pyridazinones,leur preparation et leur utilisation therapeutique
EP0164247B1 (fr) Dihydropyridines
US4766122A (en) Cyanoamidine compounds and derivatives thereof
US4766123A (en) Methylamidine compounds
JPH0196180A (ja) ベンゾイミダゾール化合物、その製造法およびこれらの化合物を含有する心機能不全治療用組成物
US4962110A (en) Pyridazinone derivatives
LU83251A1 (fr) Derives d'imidazo(4,5-b)pyridine,leur preparation et leur utilisation comme agents cardiotoniques
JPS61212583A (ja) ２‐アミノピリミジノン誘導体
JPS61212582A (ja) ジヒドロピリダジノン誘導体
EP0197664A2 (fr) Dérivés de 2-aminopyrimidinones
JPS61221177A (ja) シアノアルカンイミドアミド化合物
EP0146282A2 (fr) Composés de pyrazinone
JPS6212764A (ja) ジヒドロピリダジノン誘導体
LU83320A1 (fr) 4,5-dihydro-6-(pyridinyl)-3(2h)-pyridazinones,leur preparation et leur utilisation comme agents cardiotoniques
JPH07316162A (ja) 三環式化合物
CZ215992A3 (cs) Nové acylaminohetrazepinové deriváty, způsob výroby a farmaceutické prostředky sjejích obsahem